Dimenhydrinate: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
m (Protected "Dimenhydrinate": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(12 intermediate revisions by one other user not shown)
Line 4: Line 4:
|genericName=Dimenhydrinate
|genericName=Dimenhydrinate
|aOrAn=an
|aOrAn=an
|drugClass=antiemetic
|drugClass=[[antiemetic]]
|indicationType=treatment
|indicationType=treatment
|indication= these symptoms associated with motion sickness:
|indication=these symptoms associated with [[motion sickness]] like [[nausea]], [[vomiting]] and [[dizziness]]
*nausea
 
*vomiting
|adverseReactions=[[nausea]], [[vomiting]], [[xerostomia]] and [[sedation]]
*dizziness
|adverseReactions=[[nausea]], [[vomiting]], [[xerostomia]] and [[sedation]].
|blackBoxWarningTitle=<b><span style="color:#FF0000;">TITLE</span></b>
|blackBoxWarningTitle=<b><span style="color:#FF0000;">TITLE</span></b>
|blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content)
|blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content)
Line 16: Line 14:
*Uses for prevention and treatment of these symptoms associated with motion sickness:
*Uses for prevention and treatment of these symptoms associated with motion sickness:


::*nausea
::*[[nausea]]
::*vomiting
::*[[vomiting]]
::*dizziness
::*[[dizziness]]


===Dosage===
===Dosage===
 
*To prevent [[motion sickness]], the first dose should be taken 1/2 to 1 hour before starting activity.
*To prevent or treat [[motion sickness]], use the following dosing.
[[File:DIMENHYDRINATE1.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]
[[File:DIMENHYDRINATE1.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]
 
|offLabelAdultGuideSupport=*There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of Dimenhydrinate in adult patients.
|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of Dimenhydrinate in adult patients.
|offLabelAdultNoGuideSupport=*There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of Dimenhydrinate in adult patients.
|offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of Dimenhydrinate in adult patients.
|fdaLIADPed====Indications===
|fdaLIADPed====Indications===
*Uses for prevention and treatment of these symptoms associated with motion sickness:
*Uses for prevention and treatment of these symptoms associated with [[motion sickness]]:
::*nausea
::*[[nausea]]
::*vomiting
::*[[vomiting]]
::*dizziness
::*[[dizziness]]
*Do not use in children under 2 years of age unless directed by a doctor
*Do not use in children under 2 years of age unless directed by a doctor


Line 38: Line 36:
|offLabelPedNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of Dimenhydrinate in pediatric patients.
|offLabelPedNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of Dimenhydrinate in pediatric patients.
|contraindications=*None
|contraindications=*None
|warnings=*None
|warnings=*None.
|alcohol=Alcohol-Dimenhydrinate interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
===Precautions===
====ASK A DOCTOR BEFORE USE IF YOU HAVE====
:*A breathing problem such as [[emphysema]] or [[chronic bronchitis]].
:*[[Glaucoma]].
:*Difficulty in urination due to [[BPH|enlargement of the prostate gland]].
|clinicalTrials=====WHEN USING THIS PRODUCT====
*Marked drowsiness may occur.
*Alcohol, sedatives and tranquilizers may increase drowsiness.
*Avoid alcoholic drinks.
*Be careful when driving a motor vehicle or operating machinery*
|postmarketing=*There is limited information regarding <i>postmarketing experience</i>.
|drugInteractions=====ASK DOCTOR/PHARMACIST====
*Ask a doctor or pharmacist before use if you are taking [[sedatives]] or [[tranquilizers]].
|useInPregnancyFDA=*If pregnant or breast-feeding, ask a health professional before use.
|useInNursing=*If pregnant or breast-feeding, ask a health professional before use.
|administration=*Oral.
|monitoring=*There is limited information regarding <i>Monitoring</i>.
|IVCompat=*There is limited information regarding <i>IV Compatibility</i>.
|overdose=*In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222).
|drugBox={{Drugbox2
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 459441657
| image = Diphenhydramine-trans.png
| width = 150
<!--Combo data-->
| type = combo
| component1 = diphenhydramine
| class1 = [[antiemetic]]
| component2 = 8-chlorotheophylline
| class2 = [[stimulant]]
 
 
<!--Clinical data-->
| tradename = Dramamine
| Drugs.com = {{drugs.com|monograph|dimenhydrinate}}
| MedlinePlus = a607046
| pregnancy_AU = A
| pregnancy_US = B
| legal_AU = S2
| legal_US = OTC
| routes_of_administration = Oral, Rectal, I.V.
 
 
<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 523-87-5
| ATC_prefix = R06AA52
| PubChem = 10660
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00985
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 10210
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = JB937PER5C
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00520
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1200406
 
<!--Chemical data-->
| smiles = O=C2N(c1nc(Cl)nc1C(=O)N2C)C.O(CCN(C)C)C(c1ccccc1)c2ccccc2
| InChI = 1/C17H21NO.C7H7ClN4O2/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;1-11-4-3(9-6(8)10-4)5(13)12(2)7(11)14/h3-12,17H,13-14H2,1-2H3;1-2H3,(H,9,10)
| InChIKey = NFLLKCVHYJRNRH-UHFFFAOYAO
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H21NO.C7H7ClN4O2/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;1-11-4-3(9-6(8)10-4)5(13)12(2)7(11)14/h3-12,17H,13-14H2,1-2H3;1-2H3,(H,9,10)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = NFLLKCVHYJRNRH-UHFFFAOYSA-N
}}
|mechAction=*There is limited information regarding <i>Mechanism of action</i>.
|structure=[[File:Diphenhydramine-trans.png|thumb|none|400px|]]
|PD=*There is limited information regarding <i>Pharmacodynamics</i>.
|PK=*There is limited information regarding <i>Pharmacokinetics</i>.
|nonClinToxic=*There is limited information regarding <i>Nonclinical toxicology</i>.
|clinicalStudies=*There is limited information regarding <i>Clinical Studies</i>.
|storage=*Store at 15° to 30°C (59° to 86°F)
|packLabel=[[File:Dimenhydrinate2.jpeg|thumb|none|400px|This image is provided by the National Library of Medicine.]][[File:Dimenhydrinate3.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]
|alcohol=*Avoid alcoholic drinks.
|brandNames=*DIMENHYDRINATE ®<ref>{{Cite web | title = DIMENHYDRINATE- dimenhydrinate tablet  | url = http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b4e1e0e9-a7cf-4c10-9e1b-0f4110be0767}}</ref>
|lookAlike=* dimenhyDRINATE - diphenhydrAMINE<ref name="www.ismp.org">{{Cite web  | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>
}}
}}
[[Category:Muscarinic antagonists]]
[[Category:H1 receptor antagonists]]
[[Category:Deliriants]]
[[Category:Antiemetics]]
[[Category:Drug]]

Latest revision as of 20:00, 18 August 2015

Dimenhydrinate
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Turky Alkathery, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Overview

Dimenhydrinate is an antiemetic that is FDA approved for the treatment of these symptoms associated with motion sickness like nausea, vomiting and dizziness. Common adverse reactions include nausea, vomiting, xerostomia and sedation.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Indications

  • Uses for prevention and treatment of these symptoms associated with motion sickness:

Dosage

  • To prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activity.
  • To prevent or treat motion sickness, use the following dosing.
This image is provided by the National Library of Medicine.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

  • There is limited information regarding Off-Label Guideline-Supported Use of Dimenhydrinate in adult patients.

Non–Guideline-Supported Use

  • There is limited information regarding Off-Label Non–Guideline-Supported Use of Dimenhydrinate in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Indications

  • Uses for prevention and treatment of these symptoms associated with motion sickness:
  • Do not use in children under 2 years of age unless directed by a doctor

Dosage

This image is provided by the National Library of Medicine.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Dimenhydrinate in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Dimenhydrinate in pediatric patients.

Contraindications

  • None

Warnings

  • None.

Precautions

ASK A DOCTOR BEFORE USE IF YOU HAVE

Adverse Reactions

Clinical Trials Experience

WHEN USING THIS PRODUCT

  • Marked drowsiness may occur.
  • Alcohol, sedatives and tranquilizers may increase drowsiness.
  • Avoid alcoholic drinks.
  • Be careful when driving a motor vehicle or operating machinery*

Postmarketing Experience

  • There is limited information regarding postmarketing experience.

Drug Interactions

ASK DOCTOR/PHARMACIST

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

  • If pregnant or breast-feeding, ask a health professional before use.


Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Dimenhydrinate in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Dimenhydrinate during labor and delivery.

Nursing Mothers

  • If pregnant or breast-feeding, ask a health professional before use.

Pediatric Use

There is no FDA guidance on the use of Dimenhydrinate in pediatric settings.

Geriatic Use

There is no FDA guidance on the use of Dimenhydrinate in geriatric settings.

Gender

There is no FDA guidance on the use of Dimenhydrinate with respect to specific gender populations.

Race

There is no FDA guidance on the use of Dimenhydrinate with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Dimenhydrinate in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Dimenhydrinate in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Dimenhydrinate in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Dimenhydrinate in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Oral.

Monitoring

  • There is limited information regarding Monitoring.

IV Compatibility

  • There is limited information regarding IV Compatibility.

Overdosage

  • In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222).

Pharmacology

Template:Px
Dimenhydrinate
Combination of
diphenhydramine antiemetic
8-chlorotheophylline stimulant
Identifiers
CAS number 523-87-5
ATC code R06AA52
PubChem 10660
DrugBank DB00985
Therapeutic considerations
Pregnancy cat.

A(AU) B(US)

Legal status

Pharmacy Only (S2)(AU) OTC(US)

Routes Oral, Rectal, I.V.

Mechanism of Action

  • There is limited information regarding Mechanism of action.

Structure

Pharmacodynamics

  • There is limited information regarding Pharmacodynamics.

Pharmacokinetics

  • There is limited information regarding Pharmacokinetics.

Nonclinical Toxicology

  • There is limited information regarding Nonclinical toxicology.

Clinical Studies

  • There is limited information regarding Clinical Studies.

How Supplied

There is limited information regarding Dimenhydrinate How Supplied in the drug label.

Storage

  • Store at 15° to 30°C (59° to 86°F)

Images

Drug Images

{{#ask: Page Name::Dimenhydrinate |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

This image is provided by the National Library of Medicine.
This image is provided by the National Library of Medicine.

{{#ask: Label Page::Dimenhydrinate |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Dimenhydrinate Patient Counseling Information in the drug label.

Precautions with Alcohol

  • Avoid alcoholic drinks.

Brand Names

  • DIMENHYDRINATE ®[1]

Look-Alike Drug Names

  • dimenhyDRINATE - diphenhydrAMINE[2]

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. ↑ "DIMENHYDRINATE- dimenhydrinate tablet".
  2. ↑ "http://www.ismp.org". External link in |title= (help)
Retrieved from "https://www.wikidoc.org/index.php?title=Dimenhydrinate&oldid=1135186"